Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 09:02 am Purchase | 2025-09-30 | 13G | Talon Capital Corp. Class A Ordinary Shares TLNC | Adage Capital Management, L.P. | 2,025,000 7.890% | 2,025,000 (New Position) | Filing History |
| 2025-11-13 09:01 am Purchase | 2025-09-30 | 13G | Northpointe Bancshares, Inc. NPB | Adage Capital Management, L.P. | 1,794,104 5.220% | 1,794,104 (New Position) | Filing History |
| 2025-11-13 09:01 am Sale | 2025-09-30 | 13G | Zevra Therapeutics, Inc. ZVRA | Adage Capital Management, L.P. | 2,225,000 3.960% | -1,425,000 (-39.04%) | Filing History |
| 2025-11-13 09:01 am Purchase | 2025-09-30 | 13G | Monro, Inc. MNRO | Adage Capital Management, L.P. | 2,222,000 7.410% | 2,222,000 (New Position) | Filing History |
| 2025-11-13 09:00 am Purchase | 2025-09-30 | 13G | Highview Merger Corp. Class A Ordinary Share HVMC | Adage Capital Management, L.P. | 1,800,000 7.610% | 1,800,000 (New Position) | Filing History |
| 2025-11-13 09:00 am Sale | 2025-09-30 | 13G | Tango Therapeutics, Inc. TNGX | Adage Capital Management, L.P. | 2,511,000 2.260% | -3,394,349 (-57.48%) | Filing History |
| 2025-11-13 09:00 am Purchase | 2025-09-30 | 13G | Bright Minds Biosciences Inc. DRUG | Adage Capital Management, L.P. | 395,743 5.580% | 395,743 (New Position) | Filing History |
| 2025-11-03 4:10 pm Sale | 2025-10-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Adage Capital Management, L.P. | 1,305,175 5.290% | -1,068,910 (-45.02%) | Filing History |
| 2025-10-31 10:42 am Sale | 2025-10-29 | 13D | 89bio, Inc. ETNB | Adage Capital Management, L.P. | 0 0.000% | -9,097,587 (Position Closed) | Filing History |
| 2025-10-03 4:01 pm Purchase | 2025-09-26 | 13D | 89bio, Inc. ETNB | Adage Capital Management, L.P. | 9,097,587 6.130% | 9,097,587 (New Position) | Filing History |
| 2025-09-02 4:06 pm Purchase | 2025-08-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Adage Capital Management, L.P. | 2,374,085 11.280% | 399,500 (+20.23%) | Filing History |
| 2025-08-12 09:07 am Purchase | 2025-06-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 6,800,000 9.880% | 1,050,000 (+18.26%) | Filing History |
| 2025-08-12 09:07 am Purchase | 2025-06-30 | 13G | TScan Therapeutics, Inc. TCRX | Adage Capital Management, L.P. | 1,350,000 2.520% | 1,350,000 (New Position) | Filing History |
| 2025-08-12 09:07 am Purchase | 2025-06-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Adage Capital Management, L.P. | 8,800,000 9.870% | 3,102,395 (+54.45%) | Filing History |
| 2025-08-12 09:06 am Purchase | 2025-06-30 | 13G | Tango Therapeutics, Inc. TNGX | Adage Capital Management, L.P. | 5,905,349 5.450% | 5,905,349 (New Position) | Filing History |
| 2025-08-12 09:06 am Purchase | 2025-06-30 | 13G | DBV Technologies S.A. DBVT | Adage Capital Management, L.P. | 14,614,449 9.990% | 14,614,449 (New Position) | Filing History |
| 2025-08-12 09:06 am Purchase | 2025-06-30 | 13G | Adagio Medical Holdings, Inc. ADGM | Adage Capital Management, L.P. | 821,261 5.340% | 821,261 (New Position) | Filing History |
| 2025-08-12 09:05 am Sale | 2025-06-30 | 13G | Janux Therapeutics, Inc. JANX | Adage Capital Management, L.P. | 2,525,000 4.270% | -536,750 (-17.53%) | Filing History |
| 2025-08-12 09:05 am Sale | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 3,575,964 7.100% | -816,732 (-18.59%) | Filing History |
| 2025-08-12 09:05 am Purchase | 2025-06-30 | 13G | Immunic, Inc. IMUX | Adage Capital Management, L.P. | 10,479,337 9.990% | 9,080,737 (+649.27%) | Filing History |